TWST
NASDAQTwist Bioscience Corporation
Price$58.38+0.80 (+1.38%)
01:30 PM07:45 PM
News · 26 weeks116-33%
2025-11-022026-04-26
Mix6490d
- Insider40(63%)
- SEC Filings13(20%)
- Other8(13%)
- Earnings3(5%)
Latest news
25 items- INSIDERDirector Starovasnik Melissa A. sold $30,915 worth of shares (500 units at $61.83) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 25,222 units (SEC Form 4)4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERPresident and COO Finn Patrick John sold $141,026 worth of shares (2,321 units at $60.76), decreasing direct ownership by 0.82% to 281,808 units (SEC Form 4) to cover withholding tax4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERChief Executive Officer Leproust Emily M. exercised 9,671 shares at a strike of $8.82 and sold $630,957 worth of shares (9,671 units at $65.24) as part of a pre-agreed trading plan (SEC Form 4)4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERSEC Form 4 filed by Laponis Adam4 - Twist Bioscience Corp (0001581280) (Issuer)
- PRTwist Bioscience to Report Fiscal 2026 Second Quarter Financial Results on Monday, May 4, 2026Company to host conference call at 8:00 AM ET Investor Day Scheduled for May 21, 2026 Twist Bioscience Corporation (NASDAQ:TWST), a mid-cap growth and value biotech company, today announced that it will issue its financial results for the fiscal 2026 second quarter ended March 31, 2026, before the opening of the market on May 4, 2026. The company plans to hold a conference call and live audio webcast for analysts and investors at 8:00 a.m. Eastern Time to discuss its financial results and provide an update on the company's business. The press release with the financial results will be accessible from the company's website prior to the conference call through the Investor Relations secti
- INSIDERSEC Form 4 filed by Laponis Adam4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERSEC Form 4 filed by Laponis Adam4 - Twist Bioscience Corp (0001581280) (Issuer)
- SECSEC Form 144 filed by Twist Bioscience Corporation144 - Twist Bioscience Corp (0001581280) (Subject)
- INSIDERSEC Form 4 filed by Starovasnik Melissa A.4 - Twist Bioscience Corp (0001581280) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Twist Bioscience CorporationSCHEDULE 13G/A - Twist Bioscience Corp (0001581280) (Subject)
- INSIDERSEC Form 4 filed by Leproust Emily M.4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERSEC Form 4 filed by Cho Dennis4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERSEC Form 4 filed by Green Paula4 - Twist Bioscience Corp (0001581280) (Issuer)
- SECSEC Form 144 filed by Twist Bioscience Corporation144 - Twist Bioscience Corp (0001581280) (Subject)
- INSIDERSEC Form 4 filed by Chess Robert4 - Twist Bioscience Corp (0001581280) (Issuer)
- SECSEC Form 144 filed by Twist Bioscience Corporation144 - Twist Bioscience Corp (0001581280) (Subject)
- INSIDERChief Accounting Officer Werner Robert F. sold $11,421 worth of shares (246 units at $46.43), decreasing direct ownership by 0.45% to 54,799 units (SEC Form 4)4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERSVP of Human Resources Green Paula sold $43,408 worth of shares (935 units at $46.43), decreasing direct ownership by 0.75% to 124,401 units (SEC Form 4)4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDEROfficer Cho Dennis sold $19,731 worth of shares (425 units at $46.43), decreasing direct ownership by 0.31% to 138,257 units (SEC Form 4)4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERChief Executive Officer Leproust Emily M. sold $112,490 worth of shares (2,423 units at $46.43), decreasing direct ownership by 0.28% to 860,629 units (SEC Form 4)4 - Twist Bioscience Corp (0001581280) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Twist Bioscience CorporationSCHEDULE 13G/A - Twist Bioscience Corp (0001581280) (Subject)
- SECAmendment: SEC Form 10-Q/A filed by Twist Bioscience Corporation10-Q/A - Twist Bioscience Corp (0001581280) (Filer)
- INSIDERChief Accounting Officer Werner Robert F. sold $79,080 worth of shares (1,693 units at $46.71), decreasing direct ownership by 3% to 55,045 units (SEC Form 4)4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERChief Financial Officer Laponis Adam sold $97,390 worth of shares (2,085 units at $46.71), decreasing direct ownership by 2% to 128,291 units (SEC Form 4)4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERPresident and COO Finn Patrick John sold $200,572 worth of shares (4,294 units at $46.71), decreasing direct ownership by 1% to 284,129 units (SEC Form 4)4 - Twist Bioscience Corp (0001581280) (Issuer)
TWST FAQ
7 questionsWhat does Twist Bioscience Corporation do?
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with ImmunoPrecise Antibodies Ltd.; Victorian Clinical Genetic Services; Vivlion GmbH; and Kyowa Kirin Pharmaceutical Research, Inc. Twist...Where does TWST stock trade?
Twist Bioscience Corporation (TWST) is listed on NASDAQ.What sector and industry is TWST in?
Twist Bioscience Corporation operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.When did Twist Bioscience Corporation go public?
Twist Bioscience Corporation (TWST) completed its IPO in 2018.What are analysts saying about TWST?
Twist Bioscience Corporation has had 8 recent analyst actions on file. The most recent action was from Stephens: Overweight with a $4100.00 price target on 2025-11-04. Recent price targets range from $2700.00 to $4500.00.What companies are similar to TWST?
Notable peers in the same industry include AMGN (Amgen Inc.), GILD (Gilead Sciences Inc.), ARGX (argenx SE), RVMD (Revolution Medicines Inc.), BIIB (Biogen Inc.). Compare TWST side-by-side with any of them on Quantisnow.How can I track TWST on Quantisnow?
Quantisnow aggregates Twist Bioscience Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow TWST to receive live email and push alerts on every new disclosure.